Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZingiberRx is a topical analgesic cream formulated for the relief of joint and muscle pain. Originally developed by HealthSonix and later managed by Innovative Health Sciences, Inc. following a 2008 acquisition, the product leverages the anti-inflammatory properties of ginger (*Zingiber officinale*). The active components in ginger, such as gingerols and shogaols, are known to inhibit pro-inflammatory enzymes like cyclooxygenase (COX) and lipoxygenase (LOX), providing a natural alternative for managing musculoskeletal discomfort. The product was marketed as a topical solution for localized pain relief, though its current commercial availability is limited following shifts in the developer's corporate structure.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ZingiberRx.